Is Transforming Growth Factor-Beta. Signaling Activated In Human Hypertrophied Prostate Treated By 5-Alpha Reductase Inhibitor?

Hye Kyung Kim,Chen Zhao,Bo Ram Choi,Han Jung Chae,Do Sung Kim,Jong Kwan Park
DOI: https://doi.org/10.1155/2013/783287
2013-01-01
Disease Markers
Abstract:Background and Aim. It is well known that androgen deprivation relates to penile fibrosis, so we hypothesize that long-term treatment with 5-alphareductase inhibitors (5ARIs) may increase the risk of fibrosis of prostate. Patients and Methods. Thirty-two BPH patients who underwent transurethral resection of the prostate were enrolled. The patients were divided into two groups: group one, 16 patients underwent TURP who had been treated with tamsulosin for 2 years; group two, 16 patients underwent TURP who had been treated with combination of tamsulosin and dutasteride for at least 1 year. We evaluated the expressions of nNOS, iNOS, eNOS, TGF-beta 1, TGF-beta 2, phosphorylated-Smad2/3 (p-Smad2/3), E-cadherin, N-cadherin, and alpha-smooth muscle actin in the resected prostate tissues by western blotting, and the TGF-beta concentration was determined by ELISA kit. Results. The expressions of 3 isoforms of NOS were significantly increased in group 2 except of eNOS in lateral prostate, and the expressions of TGF-beta 1, TGF-beta 2, and p-Smad2/3 increased about 2-fold compared with group 1. In group 2, the E-cadherin expression decreased while N-cadherin expression increased significantly. Conclusions. The overexpression of nNOS may contribute to prostate smooth muscle relaxation; however, long-time treatment with 5 ARI increases the risk of fibrosis of prostate.
What problem does this paper attempt to address?